A quiet lab experiment using light and tin particles may end up reshaping how doctors think about killing tumours.
Instead of flooding the whole body with toxic drugs or radiation, researchers on both sides of the Atlantic are testing a way to literally “cook” cancer cells from within, using cheap LEDs and tiny engineered particles.
A gentler way to fight a brutal disease
For decades, cancer treatment has been a harsh trade-off. Chemotherapy, radiotherapy and major surgery save lives, but they can leave deep scars, both physical and psychological. Patients often endure months of nausea, fatigue, hair loss and lasting damage to healthy organs.
That painful reality has pushed scientists towards a simple goal: hit the tumour hard, leave the rest of the body alone. Targeted drugs and immunotherapies are steps in that direction, but they still come with side effects and high costs.
Now, a joint team from the University of Texas at Austin and the University of Porto reports a different strategy. They are testing a light-based therapy that focuses on precision rather than brute force, using nanometre‑scale tin oxide particles and near‑infrared LEDs.
This experimental technique wiped out up to 92% of skin cancer cells in lab tests, while neighbouring healthy cells remained largely unharmed.
The work, published in the journal ACS Nano, is still at an early stage, but it hints at treatments that are less aggressive, less painful and far more targeted.
How light and tin team up against cancer
The approach relies on a pairing of two key components: a source of near‑infrared light and engineered particles of tin oxide, known as SnOx nanoflakes.
Near‑infrared light is already used in medicine because it penetrates tissue more deeply than visible light and generally does not damage cells at low intensities. On its own, though, it is not enough to kill tumours.
SnOx nanoflakes change that. These particles, only a few billionths of a metre across, are designed to absorb near‑infrared light very efficiently and convert it into heat. When they cluster around or inside cancer cells and are exposed to light, they act like microscopic heaters.
➡️ India watches nervously as its main rival moves to buy 50 new warships
➡️ France rushes to Britain’s aid to design a new AI system for next-generation anti-mine warfare
➡️ 7 phrases older than 65 use that sound totally out of touch to young people
➡️ Neither vinegar nor soap: the magic trick to remove limescale from an electric kettle
➡️ Alexithymia: why some people don’t understand their own emotions
➡️ Major breakthrough: the world’s longest venomous snake is actually four distinct species
By turning light into localised heat, the nanoflakes raise the temperature around cancer cells high enough to destroy them, while the surrounding tissue stays relatively cool.
In their experiments, the team exposed cancer cells in a dish to a near‑infrared LED for around 30 minutes after adding SnOx particles:
- Skin cancer cells: up to 92% destroyed
- Colorectal cancer cells: about 50% destroyed
- Healthy cells nearby: largely preserved
The different figures reflect how various cell types handle heat and how well the particles bind to them, but in both cases the impact on malignant cells was striking.
Why use LEDs instead of lasers?
Traditional forms of phototherapy often rely on lasers, which can deliver concentrated beams of energy. Lasers are powerful but also expensive, bulky and can themselves burn or damage healthy tissue if not precisely controlled.
The new work deliberately replaces lasers with simple LEDs:
| Feature | Laser systems | Near‑infrared LEDs |
|---|---|---|
| Cost | High, specialised hardware | Low, mass‑produced components |
| Portability | Large clinical equipment | Compact, potentially wearable |
| Risk of direct tissue damage | Higher if misused | Lower at therapeutic intensities |
| Ease of use outside hospitals | Limited | Realistic in outpatient or home settings |
That shift matters. LEDs are cheap, robust and already embedded in many consumer devices. In principle, this could pave the way for portable tools that do not require large hospital machines or surgery‑theatre logistics.
From lab bench to bedside: what could this look like?
The researchers behind the project imagine a future where this LED‑and‑tin therapy, once proven safe, slots into existing cancer care rather than replacing it overnight.
One scenario involves skin cancers or tumours close to the surface. After surgical removal of the main mass, a small handheld or wearable LED device could be placed over the area. SnOx particles, delivered directly to the site, would then be activated to heat and kill any remaining cancer cells that surgeons cannot see.
A portable pad or patch, applied for short sessions after an operation, could quietly reduce the risk of relapse without another hospital admission.
Another idea is to use the method alongside other treatments. For example, lower‑dose chemotherapy might shrink a tumour first, making it easier for the nanoflakes and light to clean up the remnants without subjecting the patient to months of intense systemic toxicity.
The current project, backed by the UT Austin Portugal programme, is already looking at extending the technique to other cancers, including breast tumours. Those cancers often sit deeper under the skin, so researchers will need to test how well near‑infrared light and particles can reach and heat them safely.
Promises and unanswered questions
As hopeful as the results sound, this is not a ready‑to‑use treatment. All the data cited so far come from laboratory studies on cells, not from patients. That means multiple hurdles remain:
- How to deliver SnOx particles precisely to tumours inside the body
- How quickly the particles are cleared or broken down by the immune system
- Whether repeated heating causes any long‑term damage to surrounding tissues
- How different tumour types respond to this localised thermal stress
Regulators will also want reassurance that the tin‑based material does not accumulate in organs such as the liver or kidneys. Long‑term animal studies and, later, phased clinical trials will have to tackle these points before doctors can offer the therapy widely.
Photothermal therapy, explained simply
This research falls into a broader category known as photothermal therapy. The idea is straightforward: use light to heat up a carefully chosen agent, which then kills target cells through temperature rise.
Several materials can play the role of “heater”, including gold nanoparticles, carbon‑based structures and now tin oxide nanoflakes. What sets the UT Austin–Porto work apart is the combination of relatively low‑cost LEDs with a material that shows strong heating performance and good thermal stability over repeated cycles.
Thermal stability means the particles keep behaving the same way even after being heated and cooled multiple times. That could allow treatment plans involving several short sessions instead of a single intense blast, which might be easier on patients.
What this could change for patients
If the technique progresses through trials, it could reshape not just survival statistics but also daily life during treatment.
Many patients arrange their schedules, jobs and family responsibilities around long, exhausting chemotherapy cycles. A therapy based on short, targeted light sessions, potentially delivered in outpatient clinics or at home, would shift that balance. The psychological benefit of a less intimidating treatment process should not be underestimated.
There is also a global angle. Cancer care in low‑ and middle‑income countries is often limited by access to radiotherapy machines and costly drugs. A treatment that uses affordable LEDs, simple electronics and small doses of synthetic particles might be easier to roll out in overstretched health systems, assuming manufacturing and distribution are handled safely.
Of course, this approach will not suit every patient or cancer type. Deep, diffuse or highly aggressive tumours may still require powerful systemic drugs, complex surgery or advanced radiotherapy. Yet even if LED‑driven photothermal therapy only proves effective for a subset of cancers, such as superficial skin lesions or certain post‑surgical settings, it could reduce the need for harsher options in those cases.
For now, the tin nanoflakes and their glowing LED partners remain confined to the lab. But they sketch a future where killing cancer does not always mean waging war on the rest of the body, and where precision and gentleness sit closer together in oncology than they do today.
Originally posted 2026-02-14 11:10:42.